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Abstract
Background: Depression and anxiety are common among hemodialysis patients and affect their treatment outcomes. Dialysis
adequacy also affects the hemodialysis patients’ survival rates.
Objectives: This study aimed to evaluate the correlation between anxiety and depression with dialysis adequacy.
PatientsandMethods: In this cross-sectional study, 127 hemodialysis patients (73 males, 57.5%) with the mean age of 55.7± 17.5 were
enrolled. Demographic and recent laboratory data were collected using self-administered questionnaires and by reviewing medical
records. Dialysis adequacy measures including the Kt/V and urea reduction rate (URR) were calculated using standard formulas.
The Hospital Anxiety and Depression Scale (HADS) was used to diagnose depression and anxiety. Independent sample t-test and Chi-
square test were used to compare the values in different groups. Pearson correlations and linear regression were used to analyze
the data using SPSS version 21.
Results: The prevalence rates of depression and anxiety (HADS score≥ 8) were 31.5% and 41.7%, respectively. The prevalence of both
conditions was significantly higher in women than in men (P < 0.05). The mean values of Kt/V and URR were not different in patients
with and without depression or anxiety. The anxiety scores were correlated with age (P = 0.007, r = -0.24) and parathyroid hormone
(P = 0.04, r = -0.19). Younger age and lower parathyroid hormone were the only factors that predicted higher scores of anxiety in
linear regression. The Kt/V or URR were not significantly correlated with depression and anxiety scores.
Conclusions: Depression and anxiety are common among hemodialysis patients. There are no statistically significant correlation
between depression and anxiety and dialysis adequacy.
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1. Background
While maintenance hemodialysis (MHD) serves as the
main therapy for patients with end-stage renal disease
(ESRD), it is also associated with a high prevalence of psy-
chological problems (1). Previous studies showed that the
prevalence rates of depression and anxiety among MHD
patients range from 19.3% to 60.5%, and 27% to 52%, respec-
tively (2-5). Since depression and anxiety are correlated
with decreased quality of life, higher rates of hospitaliza-
tion (6, 7), non-adherence to medical treatment (8, 9), and
morbidity and mortality (10, 11) in MHD patients, finding
and targeting modifiable risk factors can help to reduce
these conditions. Studies in MHD patients suggest that dif-
ferent demographic and laboratory factors may be associ-
ated with depression. These include gender (12), age (13),
comorbidities (13), physical activity (12), unemployment
(12, 14), blood cortisol levels (15), inflammatory markers (13,
16, 17), albumin (13, 17), cholesterol, and hemoglobin (16).
Dialysis adequacy is another factor that has recently at-
tracted more attention to its effects on depression (18). The
urea reduction rate (URR) and Kt/V are the most common
methods for measuring dialysis adequacy. Different stud-
ies show that a Kt/v of 1.2 and a URR of more than 65% may
improve prognosis in MHD patients (19). Most studies have
examined the relationships between dialysis adequacy and
patients’ quality of life (20) and mortality (21), but there
is very little research on the relationship between dialysis
adequacy and depression or anxiety (13, 22), although it is
presumed that by improving Kt/v and clinical symptoms of
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the patients, their psychological conditions can improve
(23). With attention to the aforementioned data, and also
considering that studies conducted in different cities of
Iran reported that most patients do not receive adequate
dialysis, studies on the relationship between psychologi-
cal problems and dialysis adequacy are of a high priority
to provide better psychological services for these patients.
2. Objectives
This study aimed to determine the prevalence of de-
pression and anxiety and their potential associations with
dialysis adequacy in patients undergoing MHD in three
dialysis centers of Shahid Beheshti University of Medical
Sciences in Tehran.
3. Patients andMethods
3.1. Study Subjects
A purposive sampling method was used to select the
eligible participants for this study and the census method
was used to survey all the hemodialysis patients based on
inclusion and exclusion criteria. A total of 147 ESRD pa-
tients on MHD in three different hemodialysis units in
Tehran (Taleghani, Imam Hussein, and Labbafinejad hospi-
tals) were enrolled in this cross-sectional study. The inclu-
sion criteria were: age ≥ 18 years, hemodialysis duration
of at least three months, three times a week for four hours
each time, and willingness to participate in the study. Ex-
clusion criteria were history of psychiatric disorders prior
to MHD, history of recent hospitalization, history of be-
reavement in the past six months, physical or mental dis-
ability, and consciousness disturbances. Ten patients were
excluded due to hemodialysis duration less than three
months, two were excluded because of age < 18 years and
three were excluded due to physical and mental disabili-
ties or consciousness disturbances. Five patients refused to
participate in the study. Thus, we obtained demographic
data (age, sex, marital status, educational level and em-
ployment status) of 127 patients using standard question-
naires. The vascular access for all of the patients was ar-
teriovenous fistula. All of the participants were receiving
hemodialysis by Fresenius dialysis machine.
3.2. Diagnosing Depression and Anxiety
Hospital Anxiety and Depression Scale (HADS) was
administered to measure depression and anxiety. The
hospital anxiety and depression scale is a 14-item self-
administered measure for screening the presence and
severity of depression and anxiety symptoms in patients
in the week prior to administration of the questionnaire.
The time needed to answer it is less than 5 minutes and the
target population are people over sixteen years of age.
The hospital anxiety and depression scale has a 7-item
subscale for depression (HADS-D) and a 7-item subscale for
anxiety (HADS-A). Somatic symptoms are eliminated from
both subscales to decrease the false positive results. Thus,
HADS is a useful scale for diagnosing depression and anx-
iety symptoms in outpatients of a general hospital (24).
The Iranian version of the HADS is translated and validated
with Chronbach’s alpha coefficients of 0.86 and 0.78 for
HADS-D and HADS-A subscales, respectively (25).
Every item of the scale is scored between zero to three.
Thus, subscales of HADS are scored from zero to twenty
one. For each subscale, scores between zero and seven are
normal, eight to ten are mild, eleven to fourteen are mod-
erate and fifteen to twenty one are severe. A score of eight
was considered as the cut-off score for each subscale (26).
3.3. Measurements
Clinical data including medications, comorbidities
and the patients’ latest laboratory results (complete blood
count, biochemical profile, urea and creatinin before and
after hemodialysis) performed during the last month were
obtained from patients’ medical records. Comorbidity
was defined as presence of at least one of the following
diseases: diabetes mellitus, hypertension, congestive heart
failure, coronary artery disease, chronic lung disease, ma-
lignancy and autoimmune disorders.
The following biochemical parameters were checked
using the HITACHI 717 automatic analyzer device (RXT Tech-
nicon system, Japan): Fasting blood glucose (FBS), blood
urea nitrogen (BUN), creatinin (Cr), sodium (Na), potas-
sium (K), calcium (Ca), phosphorus (P), alkaline phos-
phatase (Alkp), cholesterol (Chol), triglyceride (TG), liver
enzymes (AST, ALT), iron (Fe), total iron binding capacity
(TIBC), and albumin (Alb). Intact parathyroid hormone
(iPTH) and ferritin were measured using the ELISA method.
Hemoglobin and hematocrit were measured using the au-
tomatic blood analyzer with Sysmex system (Sysmex Co,
Kobe, Japan).
3.4. Dialysis Adequacy
To assess the adequacy of hemodialysis, URR (27) and
Kt/v (28) were calculated by the following formulas:
(1)
Urinary Reduction Ratio
= 100×
[
1−
(
Urea After Hemodialysis
Urea Before Hemodialysis
)]
(2)
Kt
V
= −ln (R− 0.008t) + (4− 3.5R)× ∆BW
BW
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In which, K stands for the dialyzer clearance the rate
at which blood passes through the dialyzer expressed in
milliliters per minute (mL/min), t stands for time, V is
the volume of water a patient’s body contains, R is BUN
post/BUN pre and BW is body weight.
3.5. Statistical Analysis
Continuous data were tested with the Kolmogorov-
Smirnov test for normality and if necessary, logarithmic
transformations were used for analysis. Continuous vari-
ables were expressed as mean (standard deviation) and cat-
egorical values were expressed in percentages. The differ-
ences between the two groups were analyzed using inde-
pendent sample t-test, and chi-square analysis was used for
categorical data. Pearson correlations were used to deter-
mine the possible correlation between various variables
and dependent variables. The linear regression model
was also used to assess the ability of different variables
in predicting the anxiety and depression scores. Statisti-
cal significance was defined as P < 0.05. All analyses were
performed using the statistical package for the social sci-
ences, version 21.0 for windows (SPSS Inc., Chicago, USA).
This study conforms to the provisions of the declaration
of Helsinki and was approved by the ethical committee of
Shahid Beheshti University of Medical Sciences. Informed
consent was obtained from all the subjects.
4. Results
A Total number of 127 patients including 73 males
(57.5%) were studied. The mean age of the studied popu-
lation was 55.7 (17.5) years and the mean dialysis duration
was 80.9 (85.4) months. Cut-off scores of ≥ 8 in HADS-D
and HADS-A were used for diagnosing depression and anx-
iety, respectively. The mean HADS-D score in patients with
and without symptoms of depression were 11.3 (3.1) and 3.2
(2.1), respectively; and the mean HADS-A score in patients
with and without symptoms of anxiety were 12.0 (3.6) and
3.0 (2.1), respectively.
Prevalence of depression and anxiety in the studied
population were 31.5% (n = 40) and 41.7% (n = 53), re-
spectively. Basic characteristics of subjects with and with-
out depression or anxiety are compared in Tables 1 and 2.
The prevalence of depression and anxiety were not signifi-
cantly different in different subgroups regarding marital
status, educational level and presence or absence of co-
morbidities. However, the prevalence rates of depression
and anxiety were significantly higher in women compared
to men (P < 0.05). The prevalence of anxiety, but not de-
pression, was also different in age subgroups.
Table 3 shows the mean age, dialysis duration and lab-
oratory characteristics of the patients according to HADS
Table 1. Basic Characteristics of the Patients Classified According to the Hospital Anx-
iety and Depression Scale Depression Subscalea
Variable HADS-D < 8, % HADS-D≥ 8, %
Gender
Male 75.7 24.3
Female 58.5 41.5
Age, y
20 - 34 85.7 14.3
35 - 49 70.4 29.6
50 - 64 56.2 43.8
≥ 65 68.1 31.9
Marital status
Single 68.8 31.2
Married 65.2 34.8
Educational level
Illiterate 54.5 45.5
Minimally literate 64.3 35.7
Diploma 67.6 32.4
University 94.4 5.6
Comorbidityb
Yes 66.7 33.3
No 72.2 27.8
Abbreviation: HADS-D, hospital anxiety and depression scale-depression sub-
scale.
aP value < 0.05.
bComorbidity includes diabetes mellitus, hypertension, congestive heart fail-
ure, coronary artery disease, chronic lung diseases, malignancies and autoim-
mune disorders.
subscales. The mean age of the patients with symptoms of
anxiety was significantly lower than the patient without it
(50.3± 15.2 versus 59.6± 18.0, P = 0.003). Among labora-
tory variables, the mean iPTH levels in patients with anx-
iety were lower than the normal group (P < 0.05). There
were no significant differences in mean Kt/V and URR be-
tween patients with symptoms of depression or anxiety
compared to the normal group.
Upon analysis of correlations, there was no signifi-
cant correlation between depression score and indepen-
dent variables. Anxiety score was correlated with age (r =
-0.24, P = 0.007) and parathyroid hormone levels (r = -0.19,
P = 0.04). Hemoglobin, Iron, TIBC, ferritin and albumin
were not significantly correlated with depression or anx-
iety. There were also no significant correlations between
Kt/V and URR with depression and anxiety scores (Table 4).
Younger age and lower iPTH levels were the only factors
that predicted higher scores of anxiety. However, none of
the factors assessed in this study significantly predicted
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Table 2. Basic Characteristics of the Patients Classified According to the Hospital
Anxiety and Depression Scale Anxiety Subscalea
Variable HADS-D < 8, % HADS-D≥ 8, %
Gender
Male 67.6 32.4
Female 45.3 54.7
Age, y
20 - 34 57.1 42.9
35 - 49 40.7 59.3
50 - 64 43.8 56.2
≥ 65 78.7 21.3
Marital status
Single 53.1 46.9
Married 59.1 40.9
Educational level
Illiterate 45.5 54.5
Minimally literate 58.9 41.1
Diploma 55.9 44.1
University 77.8 22.2
Comorbidityb
Yes 60.9 39.1
No 55.6 44.4
Abbreviation: HADS-D, hospital anxiety and depression scale-depression sub-
scale.
aP value < 0.05.
bComorbidity includes diabetes mellitus, hypertension, congestive heart fail-
ure, coronary artery disease, chronic lung diseases, malignancies and autoim-
mune disorders.
the depression scores (Table 5).
5. Discussion
This study aimed to determine the prevalence of de-
pression and anxiety among MHD patients and also to
determine the association between these two conditions
with dialysis adequacy. We found that depression and anx-
iety are highly prevalent among MHD patients with the
prevalence rates of 31.5% and 41.7%, respectively. Prevalence
of both conditions was significantly higher in women. We
found no significant association between Kt/V and URR
with depression and anxiety. Previous studies reported a
prevalence of 19.3% to 60.5% for depression (2, 3) and a
prevalence of 27% to 52% for anxiety (4, 5) in MHD patients.
The prevalence of depression and anxiety in our study were
similar to those in Cukor et al. (29) study with a prevalence
of 29% and 45.7% for depression and anxiety, respectively.
Studies conducted in Iran reported a prevalence of 50% to
91% for depression and 20% to 60% for anxiety. For exam-
ple, Sanavi and Afshar (22) showed that the prevalence of
depression in MHD patients was 70% using the Beck de-
pression inventory. These differences can be due to the use
of various anxiety and depression scales in different stud-
ies, variations in sample sizes, locations of the study, pa-
tients’ socioeconomic status, and ethnic differences.
In our study, the prevalence of both conditions was sig-
nificantly higher in women, which is in concordance with
some other studies. Several studies suggest that the differ-
ence between women and men may be due to their greater
concerns about future and their obligations to obtain dif-
ferent social roles such as being a mother or a wife, and hav-
ing a job simultaneously, which may lead to increased anxi-
ety in women. Furthermore, female MHD patients may not
get enough emotional and financial support.
Dialysis adequacy has been considered to affect sur-
vival in MHD patients (30-33). On the other hand, it is
suggested that the presence of psychiatric disorders in-
creases the morbidity and mortality in MHD patients (10,
11). Several studies suggest that dialysis adequacy may be
inversely associated with the prevalence of depression and
anxiety. For example, Hung et al. (13) in a study on 146 MHD
patients revealed a weak association (r = 0.2) between de-
pression and Kt/V. Klaric and Klaric (18) also reported an
association between depression and dialysis adequacy in
patients treated with peritoneal dialysis but not in MHD
patients. They suggest these findings could be due to the
uniform distribution of Kt/V in MHD patients. Montinaro
et al. (26) found no differences in Kt/v means between de-
pressed and anxious patients with the normal group. Sim-
ilar to this study, we found no association between dial-
ysis adequacy with depression or anxiety. Different stud-
ies use different indices and methods for calculating dialy-
sis adequacy and this can be an obstacle in comparing the
studies. On the other hand, strong and plausible evidence
regarding the relationship between dialysis adequacy and
psychological problems are lacking. Depression and anxi-
ety are chronic conditions and since dialysis adequacy in-
dices may vary in different periods of time, they may not
represent the adequacy of dialysis simultaneously with pa-
tients’ mood.
Anxiety scores were inversely associated with patients’
age. This may be in part due to a lower ability of the
youth to cope with chronic diseases. Younger patients con-
sider dialysis a more significant impairment in compari-
son with their older counterparts since this condition puts
limitations on their active and dynamic life (34). There
were no differences in the depression and anxiety preva-
lence rates between subgroups divided by marital status,
educational level, dialysis duration, and comorbidities.
Chronic renal failure and dialysis are associated with
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Table 3. Age, Dialysis Duration and Laboratory Characteristics of the Patients According to HADS Subscalesa , b
Variable Depression Anxiety
HADS-D < 8 HADS-D≥ 8 HADS-A < 8 HADS-A≥ 8
Age, y 54.6 (18.8) 58.1 (14.1) 59.6 (18.0) 50.3 (15.2)
Dialysis duration,mon 78.4 (84.6) 87.2 (88.4) 84.5 (86.5) 75.5 (84.5)
Hemoglobin, g/dL 10.8 (1.6) 10.8 (1.8) 10.7 (1.6) 10.8 (1.7)
Iron,µg/dL 65.2 (89.5) 52.4 (25.0) 55.8 (30.4) 69.3 (114.2)
TIBC, ng/dL 249.4 (75.8) 235.9 (63.7) 250.7 (79.5) 237.1 (59.8)
Ferritin, ng/mL 421.7 (365.5) 521.3 (477.3) 414.7 (338.4) 508.3 (471.5)
Albumin, g/dL 4.1 (0.4) 4.1 (0.4) 4.0 (0.4) 4.0 (0.5)
iPTH, pg/mL 432.8 (476.0) 273.7 (242.6) 444.0 (499.2) 292.0 (251.5)
Kt/V 1.37 (0.3) 1.40 (0.3) 1.34 (0.3) 1.42 (0.3)
URR 0.67 (0.1) 0.68 (0.1) 0.67 (0.1) 0.69 (0.1)
Abbreviations: HADS-A, hospital anxiety and depression scale-anxiety subscale; HADS-D, hospital anxiety and depression scale depression subscale; iPTH, intact parathy-
roid hormone; TIBC, total iron binding capacity; URR, urea reduction ratio.
aData are expressed as mean (SD).
bP value < 0.05 for depression subscale.
Table 4. Correlations Between Depression and Anxiety Scores and Different Variables (Pearson Correlation)
Variable Depression Anxiety
r P Value r P Value
Age, y 0.17 0.06 -0.24 0.007
Dialysis duration,mon 0.03 0.7 0.05 0.5
Hemoglobin 0.05 0.5 0.00 0.9
Iron -0.06 0.4 0.18 0.4
TIBC -0.04 0.6 -0.16 0.07
Ferritin 0.04 0.6 0.04 0.6
Albumin -0.04 0.6 0.02 0.8
iPTH -0.12 0.2 -0.19 0.04
Kt/V 0.02 0.8 0.16 0.08
URR -0.01 0.9 0.09 0.3
Abbreviations: iPTH, intact parathyroid hormone; TIBC, Total iron binding capacity; URR, urea reduction ratio.
chronic inflammation (35-37). Some studies suggest that
serum hemoglobin (18, 38, 39), albumin (17, 39, 40) and cor-
tisol (15) levels are associated with depression. We found no
association between hemoglobin, iron, ferritin and albu-
min levels with depression or anxiety in our study. Anxiety
was inversely associated with intact parathyroid hormone
(iPTH) levels in our study. Part of these differences could
be due to differences in patients’ metabolism, body struc-
ture, nutritional and environmental conditions, activities
and severity of depression or anxiety.
This study has several limitations. First, we used a sin-
gle value of Kt/v and URR instead of using a mean value
during a period of time. Second, we were not able to run
a structured clinical interview to diagnose depression or
anxiety disorders and also we used the HADS question-
naire instead, which has been validated for Iranian outpa-
tients. Third, although previous studies suggest that in-
flammatory biomarkers such as C-reactive protein (CRP)
and interleukin-6 (IL-6) may be involved in developing de-
pression symptoms, we did not have information on these
biomarkers. Last but not least, we were not able to strat-
ify the patients based on individual comorbidities due to
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Table 5. Linear Regression Model of Different Variables for Prediction of Anxiety and Depression Scores
Variable Depression Anxiety
Ba 95% CI P Value Ba 95% CI P Value
Age, y 0.18 -0.01 - 0.11 0.08 -0.29 -0.16 - -0.03 0.004
Dialysis duration,mon -0.03 -0.01 - 0.01 0.7 -0.13 -0.20 - 0.01 0.2
Hemoglobin 0.05 -0.44 - 0.73 0.6 -0.05 -0.81 - 0.49 0.6
Iron -0.09 -0.02 - 0.01 0.4 0.09 -0.01 - 0.02 0.3
Albumin -0.03 -1.92 - 2.56 0.8 -0.03 -2.83 - 2.18 0.8
iPTH -0.15 -0.01 - 0.00 0.1 -0.20 -0.01 - 0.00 0.04
Kt/V 0.14 -1.40 - 5.78 0.2 0.20 -0.08 - 7.95 0.06
Abbreviations: CI, confidence interval; iPTH, intact parathyroid hormone.
aStandardized coefficient for the constant.
small number of patients in most comorbidity subgroups;
hence, we were unable to assess the role of the comorbidi-
ties separately in this study. The strengths of our study in-
clude using a single method for calculating Kt/V and URR
for all of the patients, and also a decent sample size com-
pared to other similar studies. Moreover, the study pop-
ulation was recruited from three major hospitals in three
different regions in Tehran and may serve as a good repre-
sentative of MHD patients living in Tehran.
5.1. Conclusion
In conclusion, we found no significant association be-
tween dialysis adequacy and depression or anxiety. We sug-
gest that depression and anxiety are common in hemodial-
ysis patients and to improve services to these patients,
physicians and personnel should be informed and edu-
cated about these conditions.
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